"Hepatitis B Treatment Monitoring" Package
A comprehensive laboratory test package for monitoring patients with chronic hepatitis B before and during antiviral therapy.
Quantitative determination of HBV DNA allows assessment of viral load, while serological markers help monitor the dynamics of the infectious process and the response to treatment.
The package also includes screening for antibodies to the hepatitis D virus. The package is performed as prescribed by a physician.
The timing of testing depends on the stage of the disease, the treatment being administered, and the results obtained. Additional biochemical and instrumental examinations may be required for a comprehensive assessment of the patient's condition.
Package includes:
- HBsAg - hepatitis B virus surface antigen
- Anti-HBs - antibodies to HBsAg
- HBeAg
- Anti-HBe - antibodies to HBeAg
- HBV DNA, quantitative determination (PCR; 150 IU/mL)
- Anti-HDV total — total antibodies to hepatitis D virus